Zaffer Syed serves as Entrepreneur in Residence (EIR) at TMC Innovation. He brings over 20 years of broad operational experience at publicly traded and venture backed companies in the medical device sector. Prior to TMC Innovation, Zaffer was on the executive team at Saranas, a Houston-based medical device startup. As CEO of Saranas, he led the recapitalization of the company that led to the FDA De Novo classification and commercial launch of a novel real-time internal bleed monitoring system for endovascular procedures.
Zaffer oversaw clinical development, regulatory affairs and strategic marketing at OrthoAccel Technologies, a private dental device startup focused on accelerating tooth movement in patients undergoing orthodontic treatment. Prior to working in startup ventures, Zaffer spent the first 13 years of his career in various operational roles at St. Jude Medical and Boston Scientific to support the development and commercialization of Class III implantable devices for cardiovascular and neuromodulation applications.
As an expert in the medical device field, Zaffer has published over 60 articles in scientific journals and has been invited to speak at multiple international conferences and seminars. Zaffer earned an MBA from the UCLA Anderson School of Management, an MS Biomedical Engineering from the University of Michigan and a BE Biomedical Engineering from Vanderbilt University.